Ketamine Revisited : : new insights into NMDA inhibitors / / edited by Nieves Saiz-Sapena, Manuel Granell Gil.
In the past, ketamine was considered a dangerous medication with the potential for abuse as a recreational drug. Healthcare providers were warned of its dangers and taught to fear its use. With this book, we hope to eliminate any fear and misgivings associated with this drug. It can be a useful medi...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | London : : IntechOpen,, 2022. |
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 online resource (iii, 261 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993603605204498 |
---|---|
ctrlnum |
(CKB)5580000000514515 (NjHacI)995580000000514515 (EXLCZ)995580000000514515 |
collection |
bib_alma |
record_format |
marc |
spelling |
Ketamine Revisited : new insights into NMDA inhibitors / edited by Nieves Saiz-Sapena, Manuel Granell Gil. London : IntechOpen, 2022. 1 online resource (iii, 261 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. In the past, ketamine was considered a dangerous medication with the potential for abuse as a recreational drug. Healthcare providers were warned of its dangers and taught to fear its use. With this book, we hope to eliminate any fear and misgivings associated with this drug. It can be a useful medication in many situations, some of which we describe herein. This book discusses the use of ketamine in anesthesia, pain disorders, depression, palliative care, and trauma situations. It also examines ketamine usage in developing countries. Includes bibliographical references. 1. Introduction -- 2. Ketamine and its molecular effects -- 2.1 Immediate effects -- 2.2 Disruption of NMDA channel functions by ketamine -- 2.3 Ketamine possesses delayed effects -- 3. Psychotomimetic effects of ketamine -- 4. Hypnosis -- 5. Pain -- 5.1 Control of chronic pain -- 6. Antidepressant effects of ketamine -- 7. Conclusion -- Funding -- Declaration of interest -- References. Ketamine. Anesthetics. 1-83962-831-6 Saiz-Sapena, Nieves, editor. Gil, Manuel Granell, editor. |
language |
English |
format |
eBook |
author2 |
Saiz-Sapena, Nieves, Gil, Manuel Granell, |
author_facet |
Saiz-Sapena, Nieves, Gil, Manuel Granell, |
author2_variant |
n s s nss m g g mg mgg |
author2_role |
TeilnehmendeR TeilnehmendeR |
title |
Ketamine Revisited : new insights into NMDA inhibitors / |
spellingShingle |
Ketamine Revisited : new insights into NMDA inhibitors / 1. Introduction -- 2. Ketamine and its molecular effects -- 2.1 Immediate effects -- 2.2 Disruption of NMDA channel functions by ketamine -- 2.3 Ketamine possesses delayed effects -- 3. Psychotomimetic effects of ketamine -- 4. Hypnosis -- 5. Pain -- 5.1 Control of chronic pain -- 6. Antidepressant effects of ketamine -- 7. Conclusion -- Funding -- Declaration of interest -- References. |
title_sub |
new insights into NMDA inhibitors / |
title_full |
Ketamine Revisited : new insights into NMDA inhibitors / edited by Nieves Saiz-Sapena, Manuel Granell Gil. |
title_fullStr |
Ketamine Revisited : new insights into NMDA inhibitors / edited by Nieves Saiz-Sapena, Manuel Granell Gil. |
title_full_unstemmed |
Ketamine Revisited : new insights into NMDA inhibitors / edited by Nieves Saiz-Sapena, Manuel Granell Gil. |
title_auth |
Ketamine Revisited : new insights into NMDA inhibitors / |
title_new |
Ketamine Revisited : |
title_sort |
ketamine revisited : new insights into nmda inhibitors / |
publisher |
IntechOpen, |
publishDate |
2022 |
physical |
1 online resource (iii, 261 pages) |
contents |
1. Introduction -- 2. Ketamine and its molecular effects -- 2.1 Immediate effects -- 2.2 Disruption of NMDA channel functions by ketamine -- 2.3 Ketamine possesses delayed effects -- 3. Psychotomimetic effects of ketamine -- 4. Hypnosis -- 5. Pain -- 5.1 Control of chronic pain -- 6. Antidepressant effects of ketamine -- 7. Conclusion -- Funding -- Declaration of interest -- References. |
isbn |
1-83962-831-6 |
callnumber-first |
R - Medicine |
callnumber-subject |
RD - Surgery |
callnumber-label |
RD86 |
callnumber-sort |
RD 286 K4 K483 42022 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
615 - Pharmacology & therapeutics |
dewey-full |
615.781 |
dewey-sort |
3615.781 |
dewey-raw |
615.781 |
dewey-search |
615.781 |
work_keys_str_mv |
AT saizsapenanieves ketaminerevisitednewinsightsintonmdainhibitors AT gilmanuelgranell ketaminerevisitednewinsightsintonmdainhibitors |
status_str |
n |
ids_txt_mv |
(CKB)5580000000514515 (NjHacI)995580000000514515 (EXLCZ)995580000000514515 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Ketamine Revisited : new insights into NMDA inhibitors / |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1796653233619337216 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01981nam a2200325 i 4500</leader><controlfield tag="001">993603605204498</controlfield><controlfield tag="005">20230702222454.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230702s2022 enk ob 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5580000000514515</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995580000000514515</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995580000000514515</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RD86.K4</subfield><subfield code="b">.K483 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">615.781</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Ketamine Revisited :</subfield><subfield code="b">new insights into NMDA inhibitors /</subfield><subfield code="c">edited by Nieves Saiz-Sapena, Manuel Granell Gil.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (iii, 261 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In the past, ketamine was considered a dangerous medication with the potential for abuse as a recreational drug. Healthcare providers were warned of its dangers and taught to fear its use. With this book, we hope to eliminate any fear and misgivings associated with this drug. It can be a useful medication in many situations, some of which we describe herein. This book discusses the use of ketamine in anesthesia, pain disorders, depression, palliative care, and trauma situations. It also examines ketamine usage in developing countries.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">1. Introduction -- 2. Ketamine and its molecular effects -- 2.1 Immediate effects -- 2.2 Disruption of NMDA channel functions by ketamine -- 2.3 Ketamine possesses delayed effects -- 3. Psychotomimetic effects of ketamine -- 4. Hypnosis -- 5. Pain -- 5.1 Control of chronic pain -- 6. Antidepressant effects of ketamine -- 7. Conclusion -- Funding -- Declaration of interest -- References.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Ketamine.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Anesthetics.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-83962-831-6</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saiz-Sapena, Nieves,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gil, Manuel Granell,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:17:51 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-02-11 21:29:23 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5343036890004498&Force_direct=true</subfield><subfield code="Z">5343036890004498</subfield><subfield code="b">Available</subfield><subfield code="8">5343036890004498</subfield></datafield></record></collection> |